Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69554013 | 6955401 | 3 | F | 20160823 | 20090330 | 20160823 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-14562219 | BRISTOL MYERS SQUIBB | 1.00 | DY | F | Y | 2.73000 | KG | 20160823 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69554013 | 6955401 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 15 MG, BID | U | 21436 | 15 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 69554013 | 6955401 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 69554013 | 6955401 | OT |
| 69554013 | 6955401 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 69554013 | 6955401 | Foetal exposure during pregnancy | |
| 69554013 | 6955401 | Hyperbilirubinaemia | |
| 69554013 | 6955401 | Pleural effusion | |
| 69554013 | 6955401 | Pneumonia | |
| 69554013 | 6955401 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |